Unlock instant, AI-driven research and patent intelligence for your innovation.
Production process of medicinal oil for treating meridian diseases
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A production process and medicated oil technology, applied in the field of medicine, to achieve the effect of strong cell regeneration, good lubricity, and promoting blood circulation
Pending Publication Date: 2021-06-18
GUANGZHOU YILIAN BIO TECH CO LTD
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Because the existing traditional Chinese and western medicine alleviates the disease from the perspective of treating the target, and ignores the pathological changes in the meridian pathway behind the disease, there is an urgent need for a medicinal oil production process for the treatment of meridian diseases to solve the above-mentioned problems
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0015] Embodiment 1: A kind of medicated oil production process for the treatment of meridian diseases, the medicated oil comprises the following raw material components in parts by weight: 2 parts of Panax notoginseng, 2 parts of safflower, 3 parts of Sperantospermia, 3 parts of Shenjincao, pepper fine 1 part of pungent, 1 part of longan, 0.5 part of menthol, 1 part of frankincense essential oil, 30 parts of the first aqueous phase, 0.3 part of hydroxyethyl cellulose, 10 parts of glycerin, 5 parts of propylene glycol, 0.02 part of flavoring agent, nonylphenol 0.12 parts of polyether-10, 4 parts of the second aqueous phase, 0.5 parts of nicotinamide, 0.01 parts of polyglutamic acid, 1 part of sweet almond oil, 1 part of lavender essential oil, 1 part of ginger essential oil, 2 parts of German chamomile essential oil, 2 parts jojoba essential oil, 1 part pomegranate seed essential oil, 1 part marjoram essential oil, 1 part patchouli essential oil.
[0016] In this implementatio...
Embodiment 2
[0023] Embodiment 2: A kind of medicated oil production process for the treatment of meridian diseases, the medicated oil comprises the following raw material components in parts by weight: 3 parts of Panax notoginseng, 3 parts of safflower, 4 parts of Speranthema, 4 parts of Shenjincao, pepper fine 1.5 parts of pungent, 1.5 parts of longan, 0.8 parts of menthol, 2 parts of frankincense essential oil, 33 parts of the first aqueous phase, 0.35 parts of hydroxyethyl cellulose, 13 parts of glycerin, 8 parts of propylene glycol, 0.025 parts of flavoring agent, nonylphenol 0.12 parts of polyether-10, 4.5 parts of the second aqueous phase, 0.8 parts of nicotinamide, 0.01 parts of polyglutamic acid, 1.5 parts of sweet almond oil, 1.5 parts of lavender essential oil, 1.5 parts of ginger essential oil, 3 parts of German chamomile essential oil, Jojoba essential oil 3 parts, pomegranate seed essential oil 1.5 parts, marjoram essential oil 1.5 parts, patchouli essential oil 1.5 parts.
...
Embodiment 3
[0031] Embodiment 3: A kind of medicated oil production process for the treatment of meridian diseases, the medicated oil comprises the following raw material components in parts by weight: 4 parts of Panax notoginseng, 4 parts of safflower, 5 parts of Sperancus, 5 parts of Shenjincao, pepper fine 2 parts of pungent, 2 parts of longan, 1 part of menthol, 3 parts of frankincense essential oil, 35 parts of the first aqueous phase, 0.4 parts of hydroxyethyl cellulose, 15 parts of glycerin, 10 parts of propylene glycol, 0.03 parts of flavoring agent, nonylphenol 0.13 parts of polyether-10, 5 parts of the second aqueous phase, 1 part of nicotinamide, 0.02 parts of polyglutamic acid, 2 parts of sweet almond oil, 2 parts of lavender essential oil, 2 parts of ginger essential oil, 4 parts of German chamomile essential oil, 4 parts jojoba essential oil, 2 parts pomegranate seed essential oil, 2 parts marjoram essential oil, 2 parts patchouli essential oil.
[0032] In this implementati...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
technical field [0001] The invention relates to a production process of medicated oil for treating meridian diseases, belonging to the technical field of medicine. Background technique [0002] In traditional Chinese medicine, meridians refer to the pathways through which Qi and blood run in the human body. The meridians can be divided into two types: regular and extraneous. There are twelve orthodox meridians, namely the three yin meridians of the hands and feet and the three yang meridians of the hands and feet, collectively called the "twelve meridians", which are the main channels through which qi and blood circulate. There are eight extraordinary meridians, namely Du, Ren, Chong, Dai, Yinqiao, Yangqiao, Yinwei, and Yangwei, collectively known as the "Eight Extraordinary Meridians", which have the functions of commanding, connecting and regulating the twelve meridians. Twelve meridians are the meridians derived from the twelve meridians, mainly to strengthen the connec...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.